BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 30609091)

  • 1. Detailed pathological analysis of the advancing edge of the tumour can effectively stratify clinical T4b colorectal cancer patients.
    Kim SW; Kim J; Hong SM; Yoon YS; Park IJ; Yu CS; Kim J
    Histopathology; 2019 May; 74(6):883-891. PubMed ID: 30609091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of pT sub-classification in surgical pathology of colorectal cancer.
    Pollheimer MJ; Kornprat P; Pollheimer VS; Lindtner RA; Schlemmer A; Rehak P; Langner C
    Int J Colorectal Dis; 2010 Feb; 25(2):187-96. PubMed ID: 19816699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The integration of macroscopic tumor invasion of adjacent organs into TNM staging system for colorectal cancer.
    Liang JW; Gao P; Wang ZN; Song YX; Xu YY; Wang MX; Dong YL; Xu HM
    PLoS One; 2012; 7(12):e52269. PubMed ID: 23300631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of T stage precision by integration of surgical and pathological staging in radically resected stage pT3-pT4b gastric cancer.
    Wang HH; Li K; Xu H; Sun Z; Wang ZN; Xu HM
    Oncotarget; 2017 Jul; 8(28):46506-46513. PubMed ID: 28148895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reappraisal of Serosal Invasion in Patients With T3 Colorectal Cancer by Elastic Stain: Clinicopathologic Study of 139 Surgical Cases With Special Reference to Peritoneal Elastic Lamina Invasion.
    Nakanishi Y; LeVea C; Dibaj S; Habib F; Cheney R; Kanehira K
    Arch Pathol Lab Med; 2016 Jan; 140(1):81-5. PubMed ID: 26717059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of peritoneal elastic laminal invasion improves survival stratification of pT3 and pT4a colorectal cancer: a meta-analysis.
    Odate T; Vuong HG; Mochizuki K; Oishi N; Kondo T
    J Clin Pathol; 2019 Nov; 72(11):736-740. PubMed ID: 31471468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative outcomes in oral cavity cancer with resected pT4a and pT4b.
    Liao CT; Lee LY; Hsueh C; Lin CY; Fan KH; Wang HM; Ng SH; Lin CH; Tsao CK; Chen IH; Chang KP; Huang SF; Kang CJ; Fang KH; Wang YC; Chang YL; Huang YC; Tsai CY; Yen TC
    Oral Oncol; 2013 Mar; 49(3):230-6. PubMed ID: 23063612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Impact of pT Stage and Peritoneal Invasion in Locally Advanced Colon Cancer.
    Baguena G; Pellino G; Frasson M; Roselló S; Cervantes A; García-Granero A; Giner F; García-Granero E
    Dis Colon Rectum; 2019 Jun; 62(6):684-693. PubMed ID: 30839315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Staging of colorectal cancers based on elastic lamina invasion.
    Liang WY; Wang YC; Hsu CY; Yang SH
    Hum Pathol; 2019 Mar; 85():44-49. PubMed ID: 30439370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour budding at invasive margins and outcome in colorectal cancer.
    Kanazawa H; Mitomi H; Nishiyama Y; Kishimoto I; Fukui N; Nakamura T; Watanabe M
    Colorectal Dis; 2008 Jan; 10(1):41-7. PubMed ID: 18078460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stage II colonic adenocarcinoma: a detailed study of pT4N0 with emphasis on peritoneal involvement and the role of tumour budding.
    Canney AL; Kevans D; Wang LM; Hyland JM; Mulcahy HE; O'Donoghue DP; O'Sullivan J; Geraghty R; Sheahan K
    Histopathology; 2012 Sep; 61(3):488-96. PubMed ID: 22463746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathological reporting of pT4 tumour stage in colorectal carcinomas: dotting the 'i's and crossing the 't's.
    Swamy R
    J Clin Pathol; 2010 Feb; 63(2):110-5. PubMed ID: 20154030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of therapy-relevant staging shifts in colorectal cancer through the introduction of pN1c in the 7th TNM edition.
    von Winterfeld M; Hoffmeister M; Ingold-Heppner B; Jansen L; Tao S; Herpel E; Schirmacher P; Dietel M; Chang-Claude J; Autschbach F; Brenner H; Bläker H
    Eur J Cancer; 2014 Nov; 50(17):2958-65. PubMed ID: 25281526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The apoptotic and proliferation rate of tumour budding cells in colorectal cancer outlines a heterogeneous population of cells with various impacts on clinical outcome.
    Dawson H; Koelzer VH; Karamitopoulou E; Economou M; Hammer C; Muller DE; Lugli A; Zlobec I
    Histopathology; 2014 Mar; 64(4):577-84. PubMed ID: 24111856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of perineural invasion in stages II and III colorectal cancer.
    Zhou Y; Wang H; Gong H; Cao M; Zhang G; Wang Y
    Pathol Res Pract; 2015 Nov; 211(11):839-44. PubMed ID: 26429129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis of curatively resected pT4b gastric cancer with respect to invaded organ type.
    Min JS; Jin SH; Park S; Kim SB; Bang HY; Lee JI
    Ann Surg Oncol; 2012 Feb; 19(2):494-501. PubMed ID: 21837527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis of women with pT4b breast cancer: the significance of this category in the TNM system.
    Harms K; Wittekind C
    Eur J Surg Oncol; 2009 Jan; 35(1):38-42. PubMed ID: 18215492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced expression of EphB2 that parallels invasion and metastasis in colorectal tumours.
    Guo DL; Zhang J; Yuen ST; Tsui WY; Chan AS; Ho C; Ji J; Leung SY; Chen X
    Carcinogenesis; 2006 Mar; 27(3):454-64. PubMed ID: 16272170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritumoral deposits as an adverse prognostic indicator of colorectal cancer.
    Ueno H; Hashiguchi Y; Shimazaki H; Shinto E; Kajiwara Y; Nakanishi K; Kato K; Maekawa K; Nakamura T; Yamamoto J; Hase K
    Am J Surg; 2014 Jan; 207(1):70-7. PubMed ID: 24112678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pT3 colorectal cancer revisited: a multicentric study on the histological depth of invasion in more than 1000 pT3 carcinomas-proposal for a new pT3a/pT3b subclassification.
    Foersch S; Lang-Schwarz C; Eckstein M; Geppert C; Schmitt M; Konukiewitz B; Groll T; Schicktanz F; Engel J; Gleitsmann M; Westhoff CC; Frickel N; Litmeyer AS; Grass A; Jank P; Lange S; Tschurtschenthaler M; Wilhelm D; Roth W; Vieth M; Denkert C; Nagtegaal I; Weichert W; Jesinghaus M
    Br J Cancer; 2022 Oct; 127(7):1270-1278. PubMed ID: 35864156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.